Stellate ganglion neuromodulation: A novel approach to cardiac dysfunction in myocardial infarction and beyond
Related Experiment Video
Updated: May 26, 2025
08:01
Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
8.0K
Alex S Y Wang1, Tristan W Dorey1,2
1Departments of Physiology and Pharmacology, Clinical Neurosciences, Cardiac Sciences, Biomedical Engineering, Hotchkiss Brain Institute, Libin Cardiovascular Institute, Restore Network, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
The Journal of Physiology
|February 25, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
01:26Heart Failure Drugs: Inotropic Agents
499
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
499